1. Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma
   Souvick Roy et al, 2018, Cellular Oncology CrossRef
2. Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs
   Paula Sanchon-Sanchez et al, 2023, Biomedicine & Pharmacotherapy CrossRef
3. Mechanisms of resistance to chemotherapy in non-small cell lung cancer
   Hye-Young Min et al, 2021, Archives of Pharmacal Research CrossRef
4. Negative Effect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer
   Dohun Kim et al, 2020, Journal of Clinical Medicine CrossRef
5. Anti-lung Cancer, Anti-microbial, Anti-α-glucosidase, Anti-sorbitol Dehydrogenase, and in silico Studies of Wogonoside and Isoliquiritigenin as Natural Compounds
   Xiancong Zeng et al, 2023, Journal of Oleo Science CrossRef
6. Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines
   Silvia Schmidtova et al, 2021, International Journal of Molecular Sciences CrossRef
7. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition
   Sai-Lan Liu et al, 2017, Cancer Letters CrossRef
8. Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy
   Ilaria Guerriero et al, 2020, Pharmaceuticals CrossRef
9. microRNA-1236-3p regulates DDP resistance in lung cancer cells
   Zhigang Wang et al, 2019, Open Medicine CrossRef
10. Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells
    Mostafa Heidari Majd et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
11. The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies
    Vivek Kumar et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
12. A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer
    Ahmad Nasimian et al, 2023, Computational and Structural Biotechnology Journal CrossRef
13. Nanomedicine Combats Drug Resistance in Lung Cancer
    Xiuli Zheng et al, 2024, Advanced Materials CrossRef
14. The role of tumor microenvironment in therapeutic resistance
    Beomseok Son et al, 2017, Oncotarget CrossRef
15. Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
    Dongyan Liu et al, 2021, Cell Death & Disease CrossRef
16. Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells
    Traci R. Tuttle et al, 2017, Cancer Letters CrossRef
17. Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells
    Ti-Hui Wu et al, 2019, International Journal of Molecular Sciences CrossRef
18. Seselin promotes cisplatin-induced apoptosis of AGS gastric cancer cells by inhibiting β-catenin expression
    Rong-Yaun Shyu et al, 2023, Archives of Biological Sciences CrossRef
19. Mechanistic Study of TTF-1 Modulation of Cellular Sensitivity to Cisplatin
    Cody A. Phelps et al, 2019, Scientific Reports CrossRef
20. Insights of Cisplatin Resistance in Cervical Cancer: A Decision Making for Cellular Survival
    Elizabeth Mahapatra et al, 2021, Cervical Cancer - A Global Public Health Treatise CrossRef
21. Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
    Xuetong Shen et al, 2023, Frontiers in Pharmacology CrossRef
22. Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?
    Mostafa Vaghari-Tabari et al, 2024, Biological Trace Element Research CrossRef